secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2026-08-05T20:04:32+00:00
Accession:  0001161697-26-000188
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q2 revenue $12.0M (+18% YoY), net income $0.25M, raises gross margin guidance to 62-64%
--------------------------------------------------------------------------------

- Net revenues $12.0M (+18% YoY); gross profit $7.8M (+20%); gross margin 65.1% vs 63.5% prior year.
- Net income $0.25M vs net loss ($0.2M) prior year; adjusted EBITDA $0.9M vs $0.3M.
- Updated FY2026 guidance: revenue $47.5-$48.5M (15-18% growth), gross margin 62-64%, positive adjusted EBITDA, year-end cash >$7.5M.
- Acquired connected monitoring technology asset; withdrew 510(k) for FreedomEDGE with Phesgo in U.S., shifting oncology strategy to higher volume molecules.
- Entered multi-year supply agreement; cash $8.3M at quarter end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000188/0001161697-26-000188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169726000188/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-26-000188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer